medical devices
RESILIA valves reshape lifetime care planning
RESILIA valves reshape lifetime care planning
Durability data and transcatheter reintervention options are influencing treatment decisions across Asia-Pacific
5 days ago
Tissue valve uptake hinges on data and diagnosis
Durability evidence is shifting younger patient use whilst awareness remains Australia’s main adoption barrier.
5 days ago
RESILIA data widens tissue valve options for younger patients
Awareness and price still slow adoption as durability evidence challenges mechanical valve trade-offs.
5 days ago
Coopervision pushes myopia control as standard care in Asia-Pacific
MyDay MiSight toric lenses launching in APAC first will reach 40% more children than current options.
EEG tool detects language delay in infants from birth to age 2
Regulatory barriers in mainland China are limiting the product to private hospitals until an MPA license is secured
Mirror Caring targets knee health gap with non-invasive wearable
A wearable patch tracks knee swelling and motion after exercise giving users an early warning before serious damage sets in.
What lies ahead for Taiwan’s pacemakers market?
Adoption is also likely to accelerate across high-volume cardiac centres.
India’s ultrasound systems market to reach $263m by 2034
The country accounted for 7% of the Asia Pacific market in 2025.
Cardiovascular diagnostic device market to hit $21.1b by 2034
Personalised and preventive healthcare is driving demand for connected devices.
Asia-Pacific to lead global medical device growth in 2026
Globally, the market is expected to rise to 7.3% in 2026.
Intracardiac echocardiography devices market to hit $621.3m by 2034
Key developments include three-dimensional imaging.
Airway management devices market to hit $3.82b
By end user, the hospitals segment dominated 68% of the market share in 2024.
India’s MRI systems market to see 12% CAGR growth until 2035
The country accounts for nearly 22% of the Asia-Pacific market.
What lies ahead for South Korea’s medical device market?
The government is investing over $622.1m to support next-generation medical devices.
Neurovascular thrombectomy market projected to quadruple by 2035
This is thanks to a rise in MVO interventions, shifts in device preference, and increasing prices.
Blood glucose monitoring system market to hit $25.4b by 2030
The diabetes management segment could see the highest CAGR during the period.
India’s CGM devices market eyes 5% CAGR growth through 2035
The country accounts for around 5% of the Asia Pacific market.
Most Read
1. Healthway Medical expands with Bridgepoint Health buy 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. Boustead buys 60% of UroMedTech in $6m prostate cancer bet 4. China’s healthcare defies Hang Seng slump with 0.9% gain 5. China's healthcare sector set for global breakoutResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential